<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01208142</url>
  </required_header>
  <id_info>
    <org_study_id>2010.001</org_study_id>
    <nct_id>NCT01208142</nct_id>
  </id_info>
  <brief_title>Toe Walker Gait Trial</brief_title>
  <acronym>TW</acronym>
  <official_title>Dynamic Splinting for Toe Walking: a Randomized, Controlled Study With Gait Analysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dynasplint Systems, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>McMurry University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Dynasplint Systems, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the change in ankle plantar flexion while walking,
      following treatment with the Ankle Dorsiflexion Dynasplint (AFD) for children diagnosed as
      Toe Walkers.

      For twelve weeks, patients will either receive the standard treatment or the same standard
      treatment and the Dynaslint worn at night.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Unrelated to trial
  </why_stopped>
  <start_date>September 2010</start_date>
  <primary_completion_date type="Anticipated">September 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in plantar flexion while ambulating</measure>
    <time_frame>12 weeks</time_frame>
    <description>The primary endpoint or dependent variable of this study will be the change in excessive plantar flexion while ambulating. A repeated measures analysis of variance (ANOVA) will be performed to measure kinematic change in gait patterns calculated with an ambulation laboratory test.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Gait</condition>
  <arm_group>
    <arm_group_label>Standard of care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>25 Control subjects will only receive SOC (a weekly standardized physical therapy and daily wear of an AFO).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dynasplint</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>25 Patients will receive the standard of care as well as an Ankle Flexion Dynasplint</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>standard of care treatment</intervention_name>
    <description>weekly standardized physical therapy and daily wear of an AFO</description>
    <arm_group_label>Standard of care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ankle Flexion Dynasplint</intervention_name>
    <description>Weekly standardized physical therapy, daily wear of an AFO and nightly wear of the ankle flexion Dynasplint</description>
    <arm_group_label>Dynasplint</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Toe Walking secondary to CP

          -  Idiopathic TW

          -  Inability to ambulate with initial heel-contact

          -  Inability to bear weight and stand flat-footed for over one minute

          -  Inability to stand or hop on one foot (symptomatic) for more than one minute

        Exclusion Criteria:

          -  Acid Maltase Deficiency Myopathy

          -  Acute Paralytic Poliomyelitis

          -  Spinal Muscular Atrophy-all types

          -  Stroke, ischemic or hemorrhagic, all types

          -  Multiple Sclerosis

          -  Traumatic Brain Injury (including Shaken Baby Syndrome)

          -  Unilateral ROM deficits in Knee or Hip

          -  Previous Achilles Tendon lengthening surgery

          -  Hemiplegic Cerebral Palsy

          -  Muscular Dystrophy-all types
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>The Ohio State University Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Tech University Health Sciences Center</name>
      <address>
        <city>Lubbock</city>
        <state>Texas</state>
        <zip>79430</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Lundequam P, Willis FB. Dynamic splinting home therapy for toe walking: a case report. Cases J. 2009 Nov 10;2:188. doi: 10.1186/1757-1626-2-188.</citation>
    <PMID>19946498</PMID>
  </reference>
  <reference>
    <citation>Booth MY, Yates CC, Edgar TS, Bandy WD. Serial casting vs combined intervention with botulinum toxin A and serial casting in the treatment of spastic equinus in children. Pediatr Phys Ther. 2003 Winter;15(4):216-20.</citation>
    <PMID>17057457</PMID>
  </reference>
  <reference>
    <citation>Li S, Bishop M, Sensac C. The Effect of Botulinium Toxin Type A Combined with Physical therapy on Gait in Children with idiopathic Toe Walking. Pediatric Physical Therapy. 2004 16(1):59.</citation>
  </reference>
  <reference>
    <citation>Romkes J, Hell AK, Brunner R. Changes in muscle activity in children with hemiplegic cerebral palsy while walking with and without ankle-foot orthoses. Gait Posture. 2006 Dec;24(4):467-74. Epub 2006 Jan 18.</citation>
    <PMID>16413188</PMID>
  </reference>
  <reference>
    <citation>Brouwer B, Davidson LK, Olney SJ. Serial casting in idiopathic toe-walkers and children with spastic cerebral palsy. J Pediatr Orthop. 2000 Mar-Apr;20(2):221-5.</citation>
    <PMID>10739286</PMID>
  </reference>
  <reference>
    <citation>Mulligan H, Wilmshurst E. Physiotherapy assessment and treatment for an ambulant child with cerebral palsy after botox A to the lower limbs: a case report. Pediatr Phys Ther. 2006 Spring;18(1):39-48.</citation>
    <PMID>16508533</PMID>
  </reference>
  <reference>
    <citation>Willis AW, Crowner B, Brunstrom JE, Kissel A, Racette BA. High dose botulinum toxin A for the treatment of lower extremity hypertonicity in children with cerebral palsy. Dev Med Child Neurol. 2007 Nov;49(11):818-22.</citation>
    <PMID>17979859</PMID>
  </reference>
  <reference>
    <citation>Gage JR. The role of gait analysis in the treatment of cerebral palsy. J Pediatr Orthop. 1994 Nov-Dec;14(6):701-2.</citation>
    <PMID>7814578</PMID>
  </reference>
  <reference>
    <citation>Romkes J, Brunner R. Comparison of a dynamic and a hinged ankle-foot orthosis by gait analysis in patients with hemiplegic cerebral palsy. Gait Posture. 2002 Feb;15(1):18-24.</citation>
    <PMID>11809577</PMID>
  </reference>
  <reference>
    <citation>Hicks R, Durinick N, Gage JR. Differentiation of idiopathic toe-walking and cerebral palsy. J Pediatr Orthop. 1988 Mar-Apr;8(2):160-3.</citation>
    <PMID>3350949</PMID>
  </reference>
  <reference>
    <citation>Galli M, Crivellini M, Santambrogio GC, Fazzi E, Motta F. Short-term effects of &quot;botulinum toxin a&quot; as treatment for children with cerebral palsy: kinematic and kinetic aspects at the ankle joint. Funct Neurol. 2001 Oct-Dec;16(4):317-23.</citation>
    <PMID>11853322</PMID>
  </reference>
  <reference>
    <citation>Ubhi T, Bhakta BB, Ives HL, Allgar V, Roussounis SH. Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy. Arch Dis Child. 2000 Dec;83(6):481-7.</citation>
    <PMID>11087280</PMID>
  </reference>
  <reference>
    <citation>Hemo Y, Macdessi SJ, Pierce RA, Aiona MD, Sussman MD. Outcome of patients after Achilles tendon lengthening for treatment of idiopathic toe walking. J Pediatr Orthop. 2006 May-Jun;26(3):336-40.</citation>
    <PMID>16670545</PMID>
  </reference>
  <reference>
    <citation>Weigl D, Copeliovitch L, Itzchak Y, Strauss S. Sonographic healing stages of Achilles tendon after tenomuscular lengthening in children with cerebral palsy. J Pediatr Orthop. 2001 Nov-Dec;21(6):778-83.</citation>
    <PMID>11675554</PMID>
  </reference>
  <reference>
    <citation>Gage JR. Gait analysis in cerebral palsy. London, Mac Keith Press; 1991</citation>
  </reference>
  <reference>
    <citation>Lai J, Jones M, Willis B. Efficacy of Dynasplint Splinting on PlantarflexionTone and Contracture Seen in CVA and TBI Subject: A Controlled Cross-Over Study. Arch Phys Med Rehabil. 2007 Oct;88(10)</citation>
  </reference>
  <reference>
    <citation>Willis B. Post-TBI Gait Rehabilitation. Applied Neurol. 2007 Jul;3(7):25-26.</citation>
  </reference>
  <verification_date>August 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 22, 2010</study_first_submitted>
  <study_first_submitted_qc>September 22, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 23, 2010</study_first_posted>
  <last_update_submitted>August 8, 2013</last_update_submitted>
  <last_update_submitted_qc>August 8, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 12, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>toe walker</keyword>
  <keyword>Pediatric toe walking</keyword>
  <keyword>ankle flexion</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

